Lugano, Switzerland, 1 October 2020 – The Molecular Analysis for Precision oncology (MAP) Congress is designed to answer the critical question about how to integrate the wealth of information coming from the analysis of tumour samples into daily practice.
The programme will provide oncologists with expert guidance to seek and identify actionable mutations in patient’s DNA to provide the best possible personalised treatment.
To apply for media accreditation, please fill out the media registration form.
In addition to having access to sessions, live Q&A with invited speakers, e-poster area, virtual exhibition area, and industry satellite symposia, accredited journalists will also have access to the Meeting webcasts.
MAP Press Office
MAP is a joint initiative of Cancer Research UK (CRUK), Unicancer and the European Society for Medical Oncology (ESMO).